Loading...
Market
Increased research funding for glucose metabolism in neural stem cells by Oct 2025?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Funding announcements from major research funding bodies or institutions
Story
Stanford Uses CRISPR to Delete GLUT4 Gene, Doubling Neurogenesis in Aging Mice
Oct 4, 2024, 02:19 AM
A new study from Stanford Medicine reveals that elevated glucose levels in aging neural stem cells suppress the production of new neurons in the brain. Researchers identified the GLUT4 gene, responsible for glucose transport, as a key factor in this process. Using CRISPR technology, they deleted the GLUT4 protein in the brains of old mice, reducing glucose uptake and stimulating neurogenesis, which increased twofold. The findings shed new light on how high glucose uptake suppresses neurogenesis and suggest that targeting glucose metabolism may counteract the decline in neural stem cell activity during aging.
View original story
Similar markets
Gender-affirming therapies • 25%
Immune response studies • 25%
Sex differences in disease susceptibility • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Autism • 25%
Cognitive Development • 25%
Neoteny • 25%
Other • 25%
No additional funding • 25%
Up to $10 million • 25%
$10 million to $50 million • 25%
Over $50 million • 25%
Increased funding for infectious disease research • 25%
Increased funding for chronic disease research • 25%
Increased funding for mental health research • 25%
Other funding priorities • 25%
Yes • 50%
No • 50%
